Inflammatory and coagulatory parameters linked to survival in critically ill children with sepsis - 08/01/26
, Mirjam Bachler 2
, Tobias Hell 3
, Caroline Linhart 4
, Andreas Entenmann 1
, Agnes Balog 1, Katharina Auer 5
, Petra Innerhofer 6Abstract |
Background |
Sepsis is associated with a deflection of inflammatory and coagulative parameters, since some clotting factors are known to be involved in the host’s defense against infection and inflammation. These parameters could play a crucial role in the course of sepsis and be used as prognostic markers in critically ill children.
Methods |
A total of 250 critically ill pediatric patients diagnosed with sepsis were retrospectively analyzed to identify routinely measured predictors for in-hospital mortality at the peak level of C-reactive protein. Those parameters entered multivariate logistic regression analysis as well as a decision tree for survival.
Results |
Multivariate logistic regression analysis revealed fibrinogen, platelets and activated partial thromboplastin time (aPTT) at the peak level of C-reactive protein to be predictors for survival ( p = 0.03, p = 0.01 and p = 0.02, respectively). An increase in fibrinogen and platelets is linked to survival, whereas an aPTT prolongation is associated with higher mortality; adjusted odds ratios (95% CI) for an increase of 100 mg/dl in fibrinogen are 1.35 (1.04–1.82) per 50 G/l platelets 1.94 (1.3–3.29) and 0.83 (0.69–0.96) for an aPTT prolongation of 10 s. Decision tree analysis shows that a fibrinogen level below 192 mg/dl (90.9% vs. 13% mortality) is most distinctive in non-survivors.
Conclusions |
High levels of fibrinogen and platelets as well as a non-overshooting aPTT are associated with a higher survival rate in pediatric patients with diagnosed sepsis. In particular, hypofibrinogenemia is distinctive for a high mortality rate in septic critically ill children.
Le texte complet de cet article est disponible en PDF.Keywords : Fibrinogen, Sepsis, Children, Survival, Inflammation, Coagulation, Platelets
Plan
Vol 8 - N° 1
Article 111- 2018 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
